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It has been shown in vitro that only specific dietary fibers contribute to immunity, but 
studies in  vivo are not conclusive. Here, we investigated degree of polymerization 
(DP) dependent effects of β2→1-fructans on immunity via microbiota-dependent and 
-independent effects. To this end, conventional or germ-free mice received short- or 
long-chain β2→1-fructan for 5 days. Immune cell populations in the spleen, mesenteric 
lymph nodes (MLNs), and Peyer’s patches (PPs) were analyzed with flow cytometry, 
genome-wide gene expression in the ileum was measured with microarray, and gut 
microbiota composition was analyzed with 16S rRNA sequencing of fecal samples. 
We found that β2→1-fructans modulated immunity by both microbiota and microbio-
ta-independent effects. Moreover, effects were dependent on the chain-length of the 
β2→1-fructans type polymer. Both short- and long-chain β2→1-fructans enhanced 
T-helper 1 cells in PPs, whereas only short-chain β2→1-fructans increased regulatory 
T cells and CD11b−CD103− dendritic cells (DCs) in the MLN. A common feature after 
short- and long-chain β2→1-fructan treatment was enhanced 2-alpha-l-fucosyltransfer-
ase 2 expression and other IL-22-dependent genes in the ileum of conventional mice. 
These effects were not associated with shifts in gut microbiota composition, or altered 
production of short-chain fatty acids. Both short- and long-chain β2→1-fructans also 
induced immune effects in germ-free animals, demonstrating direct effect independent 
from the gut microbiota. Also, these effects were dependent on the chain-length of 
the β2→1-fructans. Short-chain β2→1-fructan induced lower CD80 expression by 
CD11b−CD103− DCs in PPs, whereas long-chain β2→1-fructan specifically modulated 
B cell responses in germ-free mice. In conclusion, support of immunity is determined by 
the chemical structure of β2→1-fructans and is partially microbiota independent.
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inTrODUcTiOn
The intestinal tract contains the largest pool of immune cells in 
the body, which are separated by only a single layer of epithelial 
cells from an enormous amount of environmental stimuli, 
including the gut microbiota and dietary components (1). Via 
a complex of regulatory mechanisms, our immune system 
manages to be tolerant against food antigens and commensal 
microorganisms, yet a strong immune response can be raised 
against pathogens. The balance between tolerance and inflam-
matory responses is delicate and disturbances are implicated in 
an ever growing list of Western diseases, such as inflammatory 
bowel disease, allergies, diabetes, and even cancer (2). Therefore, 
modulation of the intestinal immune system with for example 
dietary fibers is considered an attractive strategy to prevent or 
treat these diseases (3).
Among the different dietary fibers, inulin β2→1-fructans have 
been studied extensively (4). β2→1-fructans are a heterogeneous 
group of polysaccharides, which can be found in several plants, 
but are most often commercially obtained from chicory (4). 
These fibers consist of several fructose subunits connected via 
β2→1 linkages, with or without a terminal glucose molecule (5). 
Chain-length of β2→1-fructans can be described by the degree 
of polymerization (DP), which ranges from 2 to 60, referring to 
the number of monomers that are part of the polymeric structure. 
Shorter polymers with a DP < 10 are often referred to as fructo-
oligosaccharide (FOS), whereas longer polymers with DP > 10 
are usually called inulin.
β2→1-fructans have been shown to modulate the immune 
system (6). For example, short-chain β2→1-fructans have been 
demonstrated to increase IgA secretion and production of IL-10 
and interferon-γ by CD4+ T cells from Peyer’s patches (PPs) in 
mice (7, 8), whereas long-chain β2→1-fructans induced higher 
numbers of dendritic cells in PPs and greater ex vivo secretion of 
IL-2, IL-10, and interferon-γ from spleen and mesenteric lymph 
node (MLN) cells after administration to rats (9). Generally, 
these immune effects have been attributed to the ability of 
β2→1-fructans to promote the expansion of immunostimula-
tory bacteria in the gut, mainly Bifidobacteria and Lactobacilli 
(10). In addition, metabolites produced after fermentation of 
β2→1-fructans by commensal gut bacteria include short-chain 
fatty acids (SCFAs), which dampen inflammatory responses by 
binding to G protein-coupled receptors GPR41, GPR43, and 
GPR109A expressed on different types of immune cells (11–14). 
Recently, we also demonstrated that β2→1-fructans can stimulate 
immune cells directly in vitro via activating pattern recognition 
receptors such as toll-like receptors (TLRs) (15). This direct 
effect on immune cells in vitro is stronger with higher DP β2→1-
fructans than with shorter DP β2→1-fructans. Thus, several 
possible mechanisms by which β2→1-fructans can modulate 
the immune system have been proposed, but the existence or 
contribution to immune effects in vivo is not clearly studied yet. 
Also, it has not been shown yet in vivo that immune modulation 
of β2→1-fructans is DP dependent. This knowledge is essential as 
it might lead to selection of effective immune modulating dietary 
fibers helpful in the arms race between dietary fiber intake and 
Western diseases (16).
Here, we performed an in vivo study in mice with well-defined 
short and long-chain β2→1-fructans to determine (1) whether 
β2→1-fructans are able to modulate the immune system in vivo, 
(2) whether there are differences between short- and long-chain 
β2→1-fructans with respect to the type of immune responses that 
are induced and (3) the direct effects of β2→1-fructans on the 
immune system.
MaTerials anD MeThODs
Mice
Specified pathogen free conventional C57BL/6OlaHsd males of 
8 weeks old were purchased from a commercial supplier (Envigo, 
Horst, the Netherlands), and C57BL/6OlaHsd male 8 weeks old 
germ-free mice were obtained from a breeding colony at the animal 
facility of the Radboud University (Nijmegen, the Netherlands). 
Samples derived from germ-free mice were routinely screened 
once every 2 weeks on sterility. In addition, samples from germ-
free mice the day before the end of the experiment were tested on 
sterility. All samples were screened on sterility by QM diagnostics 
(Nijmegen, the Netherlands) and confirmed to be sterile. At least 
2 weeks before the start of β2→1-fructans treatment all animals 
were receiving a D12450B diet (10% fat, Research Diet Services, 
Wijk bij Duurstede, the Netherlands). The mice were kept on this 
diet throughout the experiment. All experiments were approved 
by the animal ethics committee of the University of Groningen 
(Dierenexperimentencommissie Rijksuniversiteit Groningen, 
DEC-RUG).
β2→1-Fructans
Frutalose®OFP is a highly soluble powdered short-chain β2→1-
fructan also called FOS of mainly DP2-10, produced by partial 
hydrolysis of chicory inulin. Frutafit®TEX! (both obtained from 
Sensus, Roosendaal, the Netherlands), is a powdered food ingre-
dient of DP10-60, based on native chicory inulin. DP profiles of 
supplement A and B are depicted in Figure S1 in Supplementary 
Material.
Endotoxin levels were tested by Toxikon (Leuven, Belgium) 
and found to be below 0.3 × 10−3 µg−1. The fructans were dissolved 
in sterile water and given to the conventional mice by oral gavage. 
In addition, to ensure sterility of these solutions before admin-
istration to germ-free mice, short-chain β2→1-fructans were 
filtered with a 0.2 µm filter and long-chain β2→1-fructans were 
irradiated with 25 kGy (Synergy Health, Ede, the Netherlands), as 
it was to viscous for sterilization by filtration. Irridation induced 
some degradation of higher DP oligomers, but still significant 
amounts of oligomers up to DP30 were present. Sterility of the 
fructans after filtration or irradiation was tested by QM diag-
nostics (Nijmegen, the Netherlands) and confirmed to be sterile. 
Mice received 10 mg of these fibers or water only as a negative 
control by oral gavage once a day for 5 days in a row.
high-Performance anion-exchange 
chromatography (hPaec)
Colonic content from each mouse was first dissolved in PBS 
(100  mg/ml) and the supernatant was stored at −20°C after 
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separation from the debris by centrifugation. These samples 
together with cecum contents derived from the same mice as 
prepared in the same way were used to analyze for short- and 
long-chain β2→1-fructans with HPAEC, which was performed 
on an ICS5000 system (Thermo Fisher Scientific, Waltham, 
MA, USA), equipped with a Dionex CarboPac PA-1 column 
(2 mm × 250 mm) in combination with a Carbopac PA-1 guard 
column (2 mm × 50 mm). Ten microliters of the samples were 
injected into the system using a Thermo Fischer Scientific 
ICS5000 autosampler. The system was equipped with pulsed 
amperometric detection (ED40 gold electrode). The flow rate was 
0.3 ml/min, and the gradient used was 0–5 min 0.1 M NaOH, 
from 5 min in 40 min to 0.4 M NaOAc in 0.1 M NaOH; 5 min 
isocratically at 1 M NaOac in 0.1 M NaOH finally an equilibra-
tion step for 15 min at starting conditions. The software used was 
Chromeleon version 7 (Dionex). Monosugars and maltodextrin 
were used as standards.
high-Performance liquid chromatography 
(hPlc)
For SCFA analysis of cecum content, HPLC was performed to 
quantify butyric acid, propionic acid, acetic acid, lactic acid, 
and succinic acid on a Ultimate 3000 HPLC (Thermo Fisher 
Scientific, Waltham, MA, USA) equipped with an autosampler, a 
RI-101 refractive index detector (Shodex, Kawasaki, Japan), and 
an ion-exclusion Aminex HPX 8H column (7.8 mm × 300 mm) 
with a guard column (Bio-Rad, Hercules, CA, USA). The mobile 
phase was 5 mM H2SO4, and the flow rate was 0.6 ml/min at 65°C. 
Samples were injected onto the column and SCFA production 
was quantified.
Flow cytometry
Spleen, PPs, and MLNs were isolated from each mouse. PPs 
were removed from the small intestine by tightening the patch 
with tweezers and cutting it with scissors, avoiding as much as 
possible inclusion of the surrounding intestinal epithelium. Fat 
tissue was carefully removed from the MLNs with a razor blade. 
After isolation, all organs were immediately placed in RPMI, 10% 
FBS, 1% Pen/Strep on ice. Single cell suspensions were obtained 
from all organs by crushing the organs with the plunger of a 
2.5-ml syringe on 70 µm nylon cell strainers placed over a 50-ml 
tube. Red blood cells in spleen samples were lysed with a hypo-
tonic lysis buffer. Cells were stained with Fixable Viability Dye 
eFluor 50 (eBioscience, Vienna, Austria) to exclude dead cells. 
Aspecific binding to FC receptors was prevented by incubating 
the cells with anti-CD16/32 (clone 93, Biolegend, Uithoorn, the 
Netherlands) for 15 min on ice. For extracellular staining, cells 
were incubated with the desired mixture of antibodies for 30 min 
on ice. After washing, cells were fixed with FACS lysing solution 
(BD Biosciences, Breda, the Netherlands). For intracellular 
staining, fixed cells were permeabilized with PERM (eBiosci-
ence, Vienna, Austria) and subsequently stained with the desired 
antibodies for 30 min on ice. For identification of the different 
T helper cell subsets, cells were stained with antibodies against: 
CD3e (clone 17A2), CD4 (clone GK1.5), T-bet (clone 4B10), 
RORyt (clone B2D), Gata-3 (clone TWAJ), CD25 (clone PC61), 
and Foxp3 (clone FJK-16S). Appropriate isotype controls were 
used to determine specificity of the staining. To identify naive or 
antigen-experienced T cells, the following antibodies were used: 
CD3e (clone 17A2), CD4 (clone GK1.5), CD8a (clone 53-6.7), 
CD69 (clone H1.2F3), CD44 (clone IM7), and CD62L (clone 
MEL-14). B-cells were stained with: CD19 (clone 6D5), B220 
(clone RA-6B2), IgD (clone RTK2758), IgM (clone II/41), IgA 
(clone mA-6E1). For analysis of dendritic cells (DCs), other line-
ages were first excluded with CD3e (clone 17A2), CD19 (clone 
6D5), B220 (clone RA-6B2), and NK1.1 (clone PK136). Next, 
DC subsets were identified with CD11c (clone HL3), MHC-II 
(clone M5/114.15.2), CD11b (clone M1/70), CD103 (clone 
2E7), CD8a (clone 53-6.7), and CD80 (clone 16-10 A1). Samples 
were acquired with the FACSVerse (BD Biosciences, Breda, the 
Netherlands) and analyzed with Flow Jo software (Flow Jo LLC, 
OR, USA).
Transcriptomics
A part of the terminal ileum from each mouse was snap frozen 
in liquid nitrogen and stored at −80°C. RNA was isolated with 
the RNeasy kit (Qiagen, Valencia, CA, USA). Quantity of RNA 
was measured with the ND-1000 (NanoDrop Technologies, 
Thermo Fisher Scientific, Breda, the Netherlands) and quality 
of RNA was assessed with the Bioanalyzer 2100 (Agilent, Santa 
Clara, CA, USA). Total RNA (100 ng) was labeled utilizing the 
Ambion WT Expression kit (Life Technologies Ltd., Bleiswijk, 
the Netherlands) and the Affymetrix GeneChip WT Terminal 
Labeling kit (Affymetrix, Santa Clara, CA, USA). After labeling, 
samples were hybridized to Affymetrix GeneChip Mouse Gene 
1.1 ST arrays. An Affymetrix GeneTitan Instrument was used 
for hybridization, washing, and scanning of the array plates. 
Bioconductor packages integrated in an online pipeline were 
used for quality control of the data (17, 18). Probe sets were 
redefined using current genome information (19). Probes were 
reorganized based on the Entrez Gene database (remapped CDF 
v14.1.1). Robust Multiarray Analysis preprocessing algorithm 
available in the Bioconductor library affyPLM (20) was used to 
obtain normalized expression estimates from the raw intensity 
values.
Fluorescence In Situ hybridization
Another part of ileum and colon was fixed in Carnoy’s fixative 
to preserve the mucus layer. Samples were embedded in paraf-
fin and afterward 4  µm sections of tissue were made with a 
microtome (Leica Biosystems, Nussloch, Germany). Paraffin 
was removed from the tissue slides by washing 2× with 
xylene for 10  min. Next, samples were washed in decreasing 
amounts of ethanol (99, 70, 60%) and finally in dH2O. After 
washing, samples were incubated with 0.5  µg universal bacte-
rial probe EUB338 (5′-GCTGCCTCCCGTAGGAGT-3′) or 
segmented filamentous bacteria (SFB)-specifc probe SFB1008 
(5′-GCGAGCTTCCCTCATTACAAGG-3′) conjugated on the 
5′ end with Alexa 488 (Eurogentec, Maastricht, the Netherlands) 
in hybridization solution (20  mM TRIS-HCl, pH 7.4, 0.9  M 
NaCl, 0.1% weight/volume SDS) at 50°C overnight in a humid 
environment. The next day, the samples were washed in FISH 
washing buffer (20  mM TRIS-HCl, pH 7.4, 0.9  M NaCl) for 
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20 min. Tissue slides were then washed 2× for 10 min with PBS 
and incubated with DAPI solution (30 nM) for 5 min to visualize 
nuclei of the epithelial cells. After washing 2× with PBS, samples 
were mounted with mounting medium. Data were acquired with 
a SP8 Leica confocal microscope (Leica Microsystems, Son, the 
Netherlands), and images were processed afterward with Imaris 
software (Bitplane, Zurich, Switzerland).
Microbiota analysis
Fresh fecal samples obtained just after defecation were collected 
from all conventional mice before the start of fiber treatment. 
In addition, colonic content samples from these mice were 
collected at the end of the experiment. All samples were snap 
frozen in liquid nitrogen and stored at −80°C. These samples 
were used for 16S rRNA gene analysis for microbiota profiling 
with barcoded amplicons from the V1–V2 region of 16S rRNA 
genes generated using a 2-step PCR strategy that reduces the 
impact of barcoded primers on the outcome of microbial profil-
ing (21). DNA extraction was performed using a combination 
of the bead-beating-plus column method and the Maxwell 16 
Tissue LEV Total RNA purification kit (Promega, Leiden, the 
Netherlands). Beating of the fecal pellets took place as described 
before (22) but with STAR (Stool transport and recovery) buffer 
(Roche, Basel Switzerland). After centrifugation, 250 µl super-
natant was taken for the Maxwell 16 Tissue LEV Total RNA 
Purification Kit, and the DNA was eluted in 50 µl DNAse free 
water. Twenty nanograms of DNA were used for the amplifica-
tion of the 16S rRNA gene with primers 27F-DegS and 338R 
I + 338R II for 25 cycles as described before (23), only primers 
had a Universal Tag (UniTag) linkers attached; UniTag I (for-
ward) and II (reverses) (I—GAGCCGTAGCCAGTCTGC; II—
GCCGTGACCGTGACATCG). The first PCR was performed in 
a total volume of 50  µl containing 1× HF buffer (Finnzymes, 
Vantaa, Finland), 1  µl dNTP Mix (10  mM; Promega, Leiden, 
the Netherlands), 1  U of Phusion® Hot Start II High-Fidelity 
DNA polymerase (Finnzymes Vantaa, Finland), 500  nM of 
the 27F-DegS primer (23, 24) that was appended with UniTag 
1 at the 5′ end, 500  nM of an equimolar mix of two reverse 
primers, 338R I and II (24) based on three previously published 
probes EUB 338 I, II, and III (23), that were 5′-extended with 
UniTag 2, and 0.2–0.4 ng/µl of template DNA. The sequence of 
the UniTags were selected to have a GC content of ~66% and a 
minimal tendency to form secondary structures, including hair-
pin loops, heterodimers, and homodimers as assessed by the 
IDTDNA Oligoanalyzer 3.1 (Integrated DNA Technologies). 
Moreover, sequences were selected that had no matches in 16S 
rRNA gene databases [based on results of the “TestProbe” tool 
offered by the SILVA rRNA database project (25) using the SSU 
r117 database], and no prefect matches in genome databases 
with the Primer-BLAST tool (http://www.ncbi.nlm.nih.gov/
tools/primer-blast/). The size of the PCR products (~375  bp) 
was confirmed by gel electrophoresis using 5 µl of the amplifica-
tion reaction mixture on a 1% (w/v) agarose gel containing 1× 
SYBR® Safe (Invitrogen, Thermo Fisher Scientific, Waltham, 
MA, USA). Five microliters of these PCR products were taken to 
add adaptors and a 8-nt sample-specific barcode in an additional 
five cycle PCR amplification. This second PCR was performed 
in a total volume of 100 µl containing 1× HF buffer, dNTP Mix 
2 U of Phusion® Hot Start II High-Fidelity DNA polymerase, 
500  nM of a forward and reverse primer equivalent to the 
Unitag 1 and UniTag 2 sequences, respectively, that were each 
appended with an 8 nt sample-specific barcode (Hermes et al., 
in preparation) at the 5′ end. PCR products were purified with 
the magnetic beads (MagBio, London, UK) according to the 
HighPrepTM protocol of the manufactures instructions using 
20 µl Nuclease Free Water (Promega Leiden, the Netherlands) 
and quantified using the Qubit (Life Technologies, Bleiswijk, the 
Netherlands). Purified PCR products were mixed in approxi-
mately equimolar amounts and concentrated by the magnetic 
beads as the purification before. Purified amplicon pools were 
250  bp paired-end sequenced using Illumina Miseq (GATC-
Biotech, Konstanz, Germany).
The Illumina Miseq data analysis was carried out with a work-
flow employing the Quantitative Insights Into Microbial Ecology 
(QIIME) pipeline (26) and a set of in-house scripts as described 
before for Illumina Hiseq 16S rRNA gene sequences (Hermes 
et al., in preparation). The set of in-house scripts processed the 
reads as follows: reads were filtered for not matching barcodes; 
otu picking and chimera removal was done via matching the 
sequences to the Silva 111 database, with only one mismatch 
allowed, and a biom and with clustalw a multiple alignment and 
phylogenetic tree file was generated. Further outputs were gener-
ated via QIIME, such as filtered reads per sample, PD whole tree 
diversity measurements and the level 1–6 taxonomic distribu-
tions with relative abundances.
statistics
Flow cytometry data are expressed as means, error bars repre-
sent SEM. To verify whether there were significant differences 
between the groups, one way ANOVA was performed followed by 
the Dunnett’s multiple comparisons test. All tests were performed 
with Graphpad software (Prism, La Jolla, CA, USA).
Differentially expressed probe sets were identified using 
linear models, applying moderated T-statistics that implemented 
empirical Bayes regularization of SEs (27). A Bayesian hierar-
chical model was used to define an intensity-based moderated 
T-statistic, which takes into account the degree of independence 
of variances relative to the degree of identity and the relationship 
between variance and signal intensity (28).
Statistical tests for gut microbiota composition were per-
formed using R and Calypso (29), where the count data were 
not normally distributed and variances between groups were not 
equal, the Mann–Whitney U test was used.
resUlTs
β2→1-Fructans Modulate the Mucosal 
immune system In Vivo
We demonstrated previously that inulin β2→1-fructans 
stimulate immune cells directly and in a DP-dependent manner 
in vitro (15). In this in vivo study in mice, the immune effects of 
chemically characterized short (DP2-10) and long-chain chain 
FigUre 1 | β2→1-fructans modulate immune responses in vivo. C57BL/6 mice (n = 5 per group) received short-chain β2→1-fructans (short), long-chain 
β2→1-fructans (long), or water (NT) for five constitutive days by oral gavage. Spleen, Peyer’s patches (PPs), and mesenteric lymph nodes (MLNs) were isolated for 
FACS analysis of immune cell populations. (a) Percentages of Th1 cells (T-bet+) Tregs cells (CD25+Foxp3+), and CD69+ cells among CD3e+CD4+ cells 
(B) CD11chiMHC-IIhi cells negative for the lineage markers CD3e, CD19, B220, and NK1.1 were divided in the four major dendritic cell subsets with CD11b and 
CD103. Only data are shown for the organs where there was a significant difference after β2→1-fructan treatment. All data are expressed as means, error bars 
represent SEM (*p < 0.05, **p < 0.01).
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β2→1-fructans (DP10-60) were compared. To this end, conven-
tional mice received these fibers by oral gavage once a day for 
5 days. Effects were studied in the PPs, MLNs, and spleen.
Th1, Th2, Th17, and Treg cells in the different organs were 
compared between mice treated with the two β2→1-fructans 
and controls (Figure  1A). No differences were found in the 
spleen (data not shown). However, in the PPs, both short and 
long-chain β2→1-fructan induced a higher number of Th1 cells 
(p <  0.05) compared to controls. In addition, in MLNs, short-
chain β2→1-fructan but not long-chain β2→1-fructan treatment 
resulted in higher percentages of Treg cells (p < 0.05) and CD4+ T 
cells expressing the activation marker CD69 (p < 0.05). Next, we 
assessed the influence of β2→1-fructan treatment on B-cells in 
these tissues. No differences were observed in B cells in any organ 
tested (data not shown). Finally, considering the important role 
of DCs in initiating and modulating adaptive immune responses, 
we also evaluated the effect of β2→1-fructan treatment on DCs 
(Figure  1B). Strikingly, mice treated with short-chain but not 
the mice treated with long-chain β2→1-fructan had an increase 
in CD11b−CD103− DCs in the MLNs (p < 0.01) and a decrease 
in CD11b+CD103+ DCs (p < 0.05). No differences were found in 
spleen or PPs (data not shown).
Thus, β2→1-fructans can modulate the immune system locally 
in the PP and MLN in  vivo in a DP-dependent fashion. Only 
short-chain β2→1-fructan modulated DC and Treg numbers in 
MLNs.
β2→1-Fructans induce chain-length 
Dependent changes in gene expression in 
the ileum
To investigate the different impact in an unbiased manner, effects 
of the two β2→1-fructans on the host whole-genome expression 
of ileal tissue were studied with microarray. The ileum is assumed 
to be the location where β2→1-fructans interact with the mucosa 
(6). Treatment with both short and long-chain β2→1-fructan 
induced significant differential gene expression of approximately 
100 genes in the ileum (p-value < 0.01, fold-change > 1.3) com-
pared to controls (Figure 2A). Remarkably, the majority of affected 
genes were uniquely and differently regulated by either short- or 
long-chain β2→1-fructans (Figures 2B,C). There was only a min-
imal overlap in the induced responses by these β2→1-fructans. 
One of these genes was galactoside 2-alpha-l-fucosyltransferase 
2 (Fut2), an enzyme involved in glycosylation. It was among the 
top-10 most upregulated genes by both short- and long-chain 
β2→1-fructans (Figure 2D). Recently, it has been demonstrated 
that Fut2 is upregulated by microbiota-dependent stimulation of 
IL-22 production by type 3 innate lymphoid cells, which in turn 
FigUre 2 | Differential gene expression in the ileum after β2→1-fructan treatment. Whole-genome gene expression in the ileum of C57BL/6 mice (n = 4 per 
group) treated with short-chain β2→1-fructans (short), long-chain β2→1-fructans (long), or water was assessed with Affymetrix GeneChip Mouse Gene 1.1 ST 
arrays. (a) Number of genes that were considerably differentially expressed (p < 0.01, fold-change > 1.3) after β2→1-fructan treatment compared to controls. (B) 
Overlap in the number of genes differentially expressed after treatment with short-chain β2→1-fructans or long-chain β2→1-fructans. (c) Hierarchical clustering 
heatmap for each individual mouse of the 40 genes that were most highly upregulated or downregulated after treatment with short-chain β2→1-fructans or 
long-chain β2→1-fructans. (D) Gene expression relative to controls of the 10 most highly upregulated or downregulated genes after treatment with short-chain 
β2→1-fructans or long-chain β2→1-fructans. Genes previously shown to be induced by IL-22 are indicated (31).
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stimulates colonization resistance against pathogens (30). That 
IL-22 is regulated by both short- and long-chain β2→1-fructans 
was further confirmed by the observation that (i) genes known 
to be upregulated in epithelial cells by IL-22 (31) were strongly 
enriched in the top-10 most upregulated genes (Figure  2D) 
and (ii) that several of these genes clustered together after 
hierarchical cluster analysis (Figure 2C). However, short-chain 
β2→1-fructan seemed to induce a stronger response, reflected by 
higher expression of microbiota-dependent genes such as Fut2, 
SAA1, Retnlb, and Duox2 (Figures  2C,D). As upregulation of 
the IL-22-Fut2 axis is assumed to be gut microbiota dependent 
(30), these results suggest that the effects of β2→1-fructans on 
gene expression in the ileum are caused by differences in effects 
on gut microbiota. Therefore, we next studied and compared the 
microbiota composition in the mice treated with short- and long-
chain β2→1-fructans.
FigUre 3 | β2→1-fructans stimulate expansion of bacteria in ileum. (a) Overlap between the 39 most highly upregulated genes in the ileum by short-chain 
β2→1-fructans and the previously reported top-20 most upregulated genes (32) after segmented filamentous bacteria colonization. (B) Ileum sections of mice (n = 3 
per group) treated with short-chain β2→1-fructans, long-chain β2→1-fructans, or water (not treated) were stained with the universal bacterial probe EUB338 (red) 
and DAPI (green) to visualize the gut microbiota and nuclei of epithelial cells, respectively.
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short- and long-chain β2→1-Fructans Did 
not alter gut Microbiota composition
As SFB promote production of IL-22 and upregulation of Fut2 
(30), we first studied the ileum of short- and long-chain β2→1-
fructan treated animals for possible differences in colonization 
by SFB (Figure  3A). Although we observed an overall higher 
density of microbiota after FISH staining (Figure 3B), especially 
in animals receiving short-chain β2→1-fructans, we never found 
SFB in the ileum in any sample. Also by applying 16S rDNA 
sequencing in fecal samples, we excluded promotion of SFB 
in the β2→1-fructans-treated mice (data not shown), which 
suggest that other mechanisms must be responsible for FUT2 
upregulation.
Since β2→1-fructans have been shown to modulate gut micro-
biota composition (10), we analyzed gut microbiota composition 
with 16S rDNA sequencing in fecal samples before and after treat-
ment with the dietary fibers (Figure 4A). No significant differ-
ences were found in any specific bacterial group after treatment 
(data not shown). Moreover, in agreement with the SFB-specific 
FISH staining, SFB was not detected in any of the samples (data 
not shown). Redundancy analysis suggested that gut microbiota 
composition was similar between the groups before treatment, 
as expected (Figure  4B). The samples from the three groups 
posttreatment separated into three different clusters, suggesting 
that β2→1-fructans had some effect on the composition of the 
microbial community, but this separation was not significant 
(Figure 4B).
β2→1-Fructans are Degraded in the gut 
But Do not induce enhanced scFa 
Production
Next, despite the absence of differences in microbiota compo-
sition between short- and long-chain β2→1-fructan-treated 
mice, we studied possible differences in immune active SCFA 
production as explanation for the observed immune differences. 
However, concentrations of butyrate, propionate, acetate, lactic 
acid, and succinic acid in cecal samples were not different, nor 
enhanced by the two β2→1-fructans (Figure 5B). As it might be 
suggested that this might be caused by lack of fermentation of 
the β2→1-fructans, we quantified the fructans in the colon and 
cecum of β2→1-fructan-treated mice by HPAEC. Both β2→1-
fructans were undetectable, indicating completely utilization by 
the gut microbiota (Figure 5A, only plot of short-chain fructan 
is shown).
β2→1-Fructans Modulate immune 
responses in germ-Free Mice
As we could not find pronounced difference in short and long-
chain β2→1-fructans induced effects on microbiota or its degra-
dation products, we determined and compared the impact of the 
two β2→1-fructans on the mucosal immunity in germ-free mice.
As expected, β2→1-fructans were not degraded in the intestine 
of germ-free mice (Figure 6A), and no SCFAs could be detected 
(data not shown). Analysis of immune cells population in the 
FigUre 5 | β2→1-fructans are degraded in the gut but do not increase short-chain fatty acid (scFa) levels. (a) Colonic and cecal content of mice that 
received short-chain β2→1-fructans was analyzed with high-performance anion-exchange chromatography and compared to short-chain β2→1-fructan. (B) Cecal 
samples from mice (n = 5 per group) that received short-chain β2→1-fructans (short), long-chain β2→1-fructans (long), or water (NT) were analyzed with high-
performance liquid chromatography to quantify butyric acid, propionic acid, acetic acid, lactic acid, and succinic acid. Lactic acid and succinic acid were not 
detected (data not shown).
FigUre 4 | β2→1-fructan treatment does not alter gut microbiota composition. Fecal samples (n = 4–5 per group) were collected before or after treatment 
with short-chain β2→1-fructans, long-chain β2→1-fructans, or water (not treated/control). Bacterial DNA was isolated and analyzed with 16S rDNA sequencing. 
Numbers indicate individual mice before or after treatment, indicated with “F” and “C,” respectively. (a) Distribution of the different bacterial groups at the phylum 
level for all samples. (B) Redundancy analysis (RDA) for all samples at the genus level.
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FigUre 6 | β2→1-fructans modulate the immune system in germ-free mice. (a) Colonic and cecal content derived from germ-free mice that received 
short-chain β2→1-fructans was analyzed with high-performance anion-exchange chromatography and compared to short-chain β2→1-fructan. (B) Percentage of 
IgDloIgMhi cells among CD19+B220+ B-cells in the mesenteric lymph nodes of mice (n = 5 per group) after receiving short-chain β2→1-fructans (short), long-chain 
β2→1-fructans (long), or water (NT). In addition, in the Peyer’s patches (PPs) of theses mice CD80 expression as measured by the median fluorescence intensity 
(MFI) is shown for CD11b-CD103-dendritic cells (c). Data are expressed as means, error bars represent SEM, and *p < 0.05.
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PPs, MLNs, and spleens was performed in the same fashion as 
in conventional mice. Th1, Th2, Th17, and Treg cells were not 
influenced by β2→1-fructans in the absence of microbiota (data 
not shown). In contrast, we did observe effects on B-cells and DCs 
in β2→1-fructan-treated germ-free mice, and the effects were 
DP dependent. Long-chain β2→1-fructans induced enhanced 
numbers of IgDloIgMhi B-cells in the MLNs (p < 0.05, Figure 6B) 
but not in the PPs or spleen (data not shown), while short-chains 
did not have such an effect. DCs in PPs were only modulated by 
short-chain β2→1-fructans as expression of the activation marker 
CD80 was lower in PP DCs that did not express CD11b or CD103 
(p < 0.05) (Figure 6C). Only graphs of regulated cells are shown.
Microbiota-independent β2→1-Fructan-
induced changes in gene expression in 
the ileum
Also, the ileum of β2→1-fructan treated germ-free mice was 
studied by whole-genome expression with microarray. We 
found that both short- and long-chain β2→1-fructans modu-
late the gene expression in the ileum in the absence of the gut 
microbiota (Figure  7A). First, the gene profiles of short-chain 
β2→1-fructan-treated germ-free animals were compared to that 
of treated mice with a conventional microbiome to determine 
unique microbiota-dependent and microbiota-independent 
effects. The same was done for long-chain β2→1-fructan. After 
that, we compared the DP-dependent effects in the germ-free 
animals.
As shown in Figure 7B, there was only minor overlap between 
the genes affected in conventional and germ-free mice for both 
short and long-chain fructans, suggesting that β2→1-fructans 
modulate different pathways by direct interaction and by 
microbiota-dependent effects.
Strikingly, when studying DP-dependent effects in the mice 
there was also minimal overlap between differential gene expres-
sion induced by short and the long-chain treated germ-free mice 
(Figure 7C). This illustrates that similarly to what we observed 
FigUre 7 | β2→1-fructans induce differential gene expression in the ileum. Whole-genome gene expression in the ileum of germ-free mice (n = 4 per group) 
treated with short-chain β2→1-fructans (short), long-chain β2→1-fructans (long), or water was assessed with Affymetrix GeneChip Mouse Gene 1.1 ST arrays. (a) 
Number of genes that were considerably differentially expressed (p < 0.01, fold-change > 1.3) after β2→1-fructan treatment compared to controls. (B) Overlap 
between conventional and germ-free mice in the number of genes differentially expressed after treatment with short-chain β2→1-fructans or long-chain β2→1-
fructans. (c) Overlap in the number of genes differentially expressed in germ-free mice between short-chain β2→1-fructans and long-chain β2→1-fructans.
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in conventional mice, chain-length of β2→1-fructans is key in 
determining the type of induced response.
long-chain β2→1-Fructan Modulates 
B-cell response in germ-Free Mice
A heatmap of the 40 most differentially expressed genes in the 
ileum of germ-free mice after treatment with short or irradiated 
long-chain inulin further confirmed the presence of gene clusters 
specifically modulated by either short- and long-chain β2→1-
fructan (Figure  8A). In particular, long-chain β2→1-fructan 
seemed to modulate B-cell responses, since several genes involved 
in antibody production were differentially expressed, including a 
strong upregulation of IgD and CD20 (Figure  8B). These data 
correspond to the flow cytometry data, where we observed an 
increase in IgDloIgMhi B-cells in the MLNs of germ-free mice after 
inulin treatment.
DiscUssiOn
The structure–effector relationship between dietary fibers and 
health benefits in vivo is an area that deserves further exploration. 
Differences in immunomodulation by non-digestible dietary 
fibers is generally considered to depend on differences in stimula-
tion of immunomodulatory bacteria and/or their fermentation 
products such as SCFA (33). Several studies have shown that a 
diet with a high content of non-digestible fiber leads to higher 
levels of SCFAs in the intestine (34). However, we did not observe 
any differences in SCFA levels after fructan treatment. Therefore, 
it seems unlikely that the observed effects are mediated by 
SCFAs. Possibly 5 days of treatment is too short to enhance SCFA 
production.
We recently demonstrated in  vitro that the dietary fibers 
β2→1-fructans can activate immune cells directly in a chain-
length dependent manner (15). Here, we demonstrate to the best 
of our knowledge for the first time that direct effects of dietary 
fibers on immunity also occur in vivo. Our germ-free mice study 
confirms that direct effects of β2→1-fructans are also in  vivo 
chain-length dependent.
One of the major findings of our study is that the chain-length of 
β2→1-fructans is crucial in dictating the type of immune response 
in vivo. In conventional mice both fibers enhanced the number 
of Th1 cells in the PPs, but only short-chain β2→1-fructan treat-
ment increased the number of Tregs and CD11b−CD103− DCs in 
FigUre 8 | long-chain β2→1-fructans modulate B-cell responses. (a) Hierarchical clustering heatmap for each individual germ-free mouse of the 40 genes 
that were most highly upregulated or downregulated after treatment with short-chain β2→1-fructans (short) or long-chain β2→1-fructans (long) compared to controls 
(NT). (B) Gene expression relative to controls (NT) of the 10 most highly upregulated or downregulated genes after treatment with short-chain β2→1-fructans (short) 
or long-chain β2→1-fructans (long). Affected genes after long-chain β2→1-fructan treatment that are specifically expressed by B-cells are indicated.
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the MLNs. Therefore, our data seem to suggest that in response to 
short-chain β2→1-fructans CD11b−CD103− DCs migrate from 
the LP to the MLN to induce Tregs. Also, the whole-genome gene 
expression data indicate stronger immune responses in the ileum 
after short-chain β2→1-fructan treatment compared to long-
chain β2→1-fructans. These differences might reflect the fact that 
short-chain β2→1-fructans are fermented earlier and more read-
ily in the gastro-intestinal tract than long-chain β2→1-fructans 
due to the shorter polymeric structure (35, 36). The highest con-
centration of immune cells can be found in the ileum, where the 
mucus layer is much thinner compared to the colon (1). Several 
bacterial species that occupy this niche are known to interact with 
the immune system (37). Targeting these bacteria with relatively 
easily digestible short-chain β2→1-fructans might therefore be 
an effective strategy for modulation of immune responses.
A second, and very important finding is the demonstration of 
effects of β2→1-fructans on the immune system in the absence 
of the microbiota by using germ-free mice. In these mice, we 
observed a clear difference between short- and long-chain 
β2→1-fructan. These differences could be due to differential 
direct interactions with pattern recognition receptors such as 
TLRs on immune cells, as described previously (15). Long-chain 
β2→1-fructans, but not short-chain β2→1-fructans, induced 
strong modulation of B-cell responses in germ-free mice. Long-
chain β2→1-fructans have been shown to activate TLR2 more 
strongly in vitro (15) and could have activated TLRs expressed 
on B-cells more strongly than for short-chain fructans in vivo. 
TLR ligands are well known for their ability to activate B-cells 
(38). Alternatively, long-chain β2→1-fructans could have 
activated B-cells in antigen-specific manner in germ-free mice. 
Presumably, 5 days of treatment with long-chain β2→1-fructans 
would be too short to detect specific antibodies. However, we did 
observe upregulation of IgD and CD20 in the ileum in germ-free 
mice treated with long-chain β2→1-fructans, which may indicate 
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expansion of antigen-specific B-cells, before class-switching to 
another isotype such as IgA.
To the best of our knowledge, we demonstrate for the first 
time that β2→1-fructan treatment can enhance Fut2 expression, 
which is an enzyme involved in fucosylation of epithelial cells in 
the gut. This effect was observed with both DPs. Fut2 was recently 
shown to be induced by microbiota-dependent (especially SFB) 
stimulation of IL-22 production by type 3 innate lymphoid cells, 
which promoted colonization resistance against mucosal patho-
gens (30, 31, 39). Here, we observed that several genes such as 
Fut2, SAA1, Retnlb, and Duox2 that were previously shown to 
be induced by IL-22 (31) were highly upregulated in the ileum 
after treatment with β2→1-fructans. Fut2 induced upregulation 
by β2→1-fructans may therefore be a novel mechanism by which 
these dietary fibers contribute to improved colonization of bacte-
ria and reported health effects (6).
Although we excluded that SFB colonization was responsible 
for Fut2 expression, we do not exclude that β2→1-fructans 
enhanced other gut microbes that induced Fut2 expression. 
Other commensals, such as Bacteroides, have been shown to 
induce epithelial fucosylation as well (40, 41). However, we did 
not find a significant shift in gut microbiota composition in fecal 
samples after β2→1-fructan treatment. However, FISH staining 
of ileum samples suggests higher number of bacteria in the ileum 
after β2→1-fructan treatment. Therefore, it remains possible 
that β2→1-fructans induced local expansion of specific bacte-
rial species in the small intestine, which subsequently enhanced 
expression of Fut2 in the epithelium.
In humans, application of β2→1-fructans to induce upregu-
lation of Fut2 for enhancement of resistance against mucosal 
pathogens (30, 31, 39) might be more complex than in mice. 
Approximately 20% of the human population lacks a functional 
copy of Fut2, which are referred to as non-secretors (42). The role 
of Fut2 in development of several diseases has been demonstrated 
by comparing secretor and non-secretors. The Fut2 non-secretors 
have a different microbiota composition with less Bifidobacteria 
(43) and are less susceptible to enteric viruses (44), but are more 
susceptible to Crohn’s disease (45). Fut2 manipulation with 
dietary fibers such as β2→1-fructans may therefore be an inter-
esting approach to alleviate symptoms or frequency of intestinal 
diseases in the 80% of secretors.
In conclusion, our data suggest that rational design of β2→1-
fructans formulations with different chain-lengths is a promising 
and probably a necessary approach to achieve the desired effect 
in different target populations. We demonstrate that effects can be 
both microbiota dependent and independent. Moreover, although 
dietary fibers are considered as beneficial for health in general, 
our data demonstrate that at least in case of β2→1-fructans this 
depends on the chain length of the fiber.
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FigUre s1 | Degree of polymerization (DP) distribution in short- and 
long-chain β2→1-fructan. DP distribution in short-chain β2→1-fructan (short) 
and long-chain β2→1-fructan.
FigUre s2 | Facs plots T cells. gating strategy and representative Facs 
plots (mesenteric lymph nodes sample) for identifying T cell subsets. 
(a) Among CD3+CD4+ T cells the percentage of Tregs (Foxp3+CD25+), Th1 cells 
(T-bet+), Th17 cells (RORgt+), and Th2 cells (GATA-3+) was identified. Percentage 
of cells stained with isotype control was subtracted to determine the percentage 
of true positive cells. (B) Percentages of naïve (CD44loCD62Lhi), memory cells 
(CD44hiCD62Lhi), and effector cells (CD44hiCD62Llo) among CD3+CD4+ and 
CD3+CD8+ cells. In addition, the percentage of CD69+ cells was identified among 
CD3+CD4+ and CD3+CD8+ cells.
FigUre s3 | Facs plots B cells and dendritic cells (Dcs). Gating strategy 
and representative FACS plots (mesenteric lymph nodes sample) for identifying B 
cell and DC subsets. (a) B cells were identified as CD19+B220+ and further 
divided in IgDhiIgMlo, IgDhiIgMhi, or IgDloIgMhi. In addition, IgA-producing B cells 
were identified as IgD−IgA+ (B) DCs were identified as lineage negative 
(CD3−CD19−B220−NK1.1−) and CD11chiMHC-IIhi. These cells were further divided 
into four subsets based on the expression of CD11b and CD103. In addition, 
CD80 expression was assessed for each DC subset.
FigUre s4 | segmented filamentous bacteria (sFB) Fish staining. A 
representative image (one mouse treated with short-chain β2→1-fructans) of 
ileum samples fixed in Carnoy’s fixative that were stained with SFB-specifc probe 
SFB1008 conjugated to Alexa Fluor 488 (green) and DAPI (blue). Some green 
spots were identified, but they lacked the typical morphology of SFB.
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